US Broker Ratings

Harmony Biosciences Holdings, Inc. (HRMY) Stock Analysis: Exploring a 26% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a dynamic player in the biotechnology sector, presents a compelling case for investors with its focus on innovative therapies for rare neurological diseases. Headquartered..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A High Potential Play with 33.49% Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC), a prominent player in the healthcare plans industry, is capturing investor attention with its impressive growth trajectory and substantial upside potential. The company, founded in..

ICU Medical, Inc. (ICUI) Stock Analysis: Potential Upside and Buy Ratings Make It a Healthcare Contender

ICU Medical, Inc. (NASDAQ: ICUI) stands at a pivotal juncture in the healthcare sector, presenting an intriguing opportunity for investors. With a market capitalization of $4.04 billion, this U.S.-based company..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 62.72% Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector specializing in over-the-counter health and wellness solutions, offers investors an intriguing opportunity, particularly with its potential upside of..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Navigating a High-Stakes Biotech Landscape with Uncertain Yet Promising Clinical Trials

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning name in the biotechnology sector, is captivating investor attention with its ambitious pipeline of biologics aimed at combating a range of inflammatory and..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A 23% Potential Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a key player in the biotechnology sector, is making waves with its focus on neurological and psychiatric disorders. The Canadian-based company currently boasts a market..

Concentra Group Holdings (CON) Stock Analysis: A Healthcare Leader with 4.66% Upside

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a prominent player in the healthcare sector, primarily focuses on providing occupational health services across the United States. With a market capitalization of..

Privia Health Group, Inc. (PRVA) Stock Analysis: Exploring a Potential 29% Upside with Solid Revenue Growth

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector, especially in its niche of health information services. With a market capitalization of $3.11 billion, this Arlington,..

Arrowhead Pharmaceuticals (ARWR): Analyzing the Biotech Firm’s 20% Upside Potential Amidst Analyst Consensus

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands as a significant player in the biotechnology sector, focusing on developing innovative medicines for intractable diseases. With a market capitalization of $12.05 billion, this..

Protagonist Therapeutics, Inc. (PTGX) Stock Report: Exploring the Potential of a $8.72 Billion Biotech Innovator

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a prominent player in the biotechnology sector, is making waves with its promising pipeline of therapeutic candidates. With a market capitalization of $8.72 billion, this..

Surgery Partners, Inc. (SGRY) Stock Analysis: Unveiling a 22.85% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY) is making waves in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.98 billion, the company stands as..

Alvotech (ALVO) Stock Analysis: Exploring a Potential 111% Upside in the Biosimilar Market

Investors looking for opportunities in the healthcare sector may find Alvotech (NASDAQ: ALVO) an intriguing prospect. Specializing in the development and manufacturing of biosimilar medicines, Alvotech is positioned at the..

Zai Lab Limited (ZLAB) Stock Analysis: A Compelling 78.67% Potential Upside in Biotech Innovation

Zai Lab Limited (NASDAQ: ZLAB), a leading player in the biotechnology sector, offers a promising investment opportunity with a remarkable potential upside of 78.67%, according to analyst ratings. Despite the..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A 29% Upside Potential Amidst Promising Neurological Treatments

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a pioneering biopharmaceutical company in the healthcare sector, is making waves with its focus on neurological and rare diseases. With a market capitalization of $4.35..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: A Healthcare Giant with 25.6% Revenue Growth and Strong Buy Ratings

BrightSpring Health Services, Inc. (BTSG), a leader in the healthcare sector, particularly in health information services, has demonstrated a robust performance trajectory that has caught the attention of investors and..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook on a Biotech Trailblazer with a 17% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has been making waves in the biotechnology sector, offering promising therapeutic solutions for central nervous system (CNS) disorders. With a significant market cap of $12.4..

TransMedics Group, Inc. (TMDX)

⚠️ No article content returned.

..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in Medical Distribution

Henry Schein, Inc. (NASDAQ: HSIC) is a dominant player in the healthcare sector, specializing in medical distribution. With a market cap of $9.74 billion, the company provides essential healthcare products..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Insights into a Biotech Powerhouse with a Compelling 42% Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotech sector with its innovative approaches to drug delivery and its robust financial performance. With a market capitalization of $9.72..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds